- Home
- BANR vs CLDX Comparison
BANR vs CLDX Comparison
Compare BANR & CLDX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | BANR | CLDX |
|---|---|---|
| Founded | 1890 | N/A |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Major Banks | Biotechnology: In Vitro & In Vivo Diagnostic Substances |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.2B | 1.9B |
| IPO Year | 1995 | 2008 |
Fundamental Metrics
Financial Performance| Metric | BANR | CLDX |
|---|---|---|
| Price | $62.72 | $27.42 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 6 | 10 |
| Target Price | ★ $71.20 | $44.10 |
| AVG Volume (30 Days) | 187.3K | ★ 783.9K |
| Earning Date | 01-21-2026 | 11-10-2025 |
| Dividend Yield | ★ 3.19% | N/A |
| EPS Growth | ★ 14.84 | N/A |
| EPS | ★ 5.49 | N/A |
| Revenue | ★ $640,027,000.00 | $2,599,000.00 |
| Revenue This Year | $0.96 | N/A |
| Revenue Next Year | $7.48 | $19.70 |
| P/E Ratio | $11.42 | ★ N/A |
| Revenue Growth | ★ 7.86 | N/A |
| 52 Week Low | $54.01 | $14.40 |
| 52 Week High | $72.58 | $30.50 |
Technical Indicators
Market Signals| Indicator | BANR | CLDX |
|---|---|---|
| Relative Strength Index (RSI) | 38.10 | 54.47 |
| Support Level | $66.40 | $25.51 |
| Resistance Level | $67.95 | $27.92 |
| Average True Range (ATR) | 1.08 | 1.11 |
| MACD | -0.53 | -0.08 |
| Stochastic Oscillator | 2.35 | 64.39 |
Price Performance
Historical ComparisonAbout BANR Banner Corporation
Banner Corp is a bank holding company. It wholly owns one subsidiary bank, Banner Bank. The Bank's primary business is that of traditional banking institutions, accepting deposits and originating loans in locations surrounding its offices in Washington, Oregon, California, Idaho and Utah. Banner Bank also actively participates in the secondary loan markets, engaging in mortgage banking operations largely through the origination and sale of one to four family residential loans.
About CLDX Celldex Therapeutics Inc.
Celldex Therapeutics Inc is a biopharmaceutical company. It is focused on the development and commercialization of several immunotherapy technologies and other cancer-targeting biologics. The company is also engaged in clinical trials for products targeting breast cancer, metastatic melanoma, lung cancer, solid tumors, and ovarian cancer. It has single operating and reportable segment that operates in the business of development, manufacturing and commercialization of novel therapeutics for human health care.